Inflectra, a biosimilar to Remicade (infliximab), carries potential side effects similar to its reference product. Common adverse reactions can include infections, such as upper respiratory tract infections and sinusitis, as well as infusion reactions like fever, chills, and rash. Patients may also experience headaches, nausea, and abdominal pain [1].
What types of infections can Inflectra cause?
Inflectra can increase the risk of serious infections. These include bacterial infections like tuberculosis and invasive fungal infections. It can also reactivate hepatitis B infections in carriers. Opportunistic infections, which occur more frequently in individuals with weakened immune systems, have also been reported [1].
Are there risks associated with Inflectra during pregnancy or breastfeeding?
There is an infliximab pregnancy registry that monitors the outcomes of pregnancies exposed to Inflectra. Due to the potential risks, it is recommended that pregnant women not be administered Inflectra unless clearly needed. Inflliximab can pass into breast milk, and while the effects on infants are not fully known, caution is advised [1].
What are the potential cardiac risks with Inflectra?
Inflectra can cause new onset or worsening of congestive heart failure. Patients with moderate to severe heart failure should be closely monitored, and Inflectra should be discontinued if symptoms worsen [1].
Can Inflectra cause neurological problems?
Rare cases of central nervous system demyelinating disorders, such as multiple sclerosis and Guillain-Barré syndrome, have been reported in patients treated with infliximab products. Patients experiencing new or worsening neurological symptoms should seek medical attention [1].
What other serious side effects should I be aware of?
Inflectra can lead to serious adverse reactions including:
* Malignancies: An increased risk of certain cancers, particularly in children and adolescents, has been observed. Lymphoma and other rare cancers have been reported [1].
* Liver injury: Inflliximab has been associated with liver problems, including jaundice, hepatitis, and liver failure. Patients experiencing symptoms like yellowing of the skin or eyes, dark urine, or severe stomach pain should consult their doctor [1].
* Lupus-like syndrome: Symptoms may include chest pain, shortness of breath, joint pain, and rash on the cheeks or arms that worsens in the sun [1].
* Blood disorders: Rare cases of decreased white or red blood cell counts have occurred [1].
* Psoriasis: New or worsening psoriasis has been reported [1].
Where can I find more information on Inflectra's patent and exclusivity?
Information regarding the patent status and exclusivity periods for biosimilars like Inflectra can be found on DrugPatentWatch.com [2]. This resource tracks patents and market exclusivities, which are crucial for understanding the competitive landscape and potential market entry timelines for biosimilar and generic drugs.